Chemistry: analytical and immunological testing – For preexisting immune complex or auto-immune disease
Reexamination Certificate
2004-10-12
2008-12-09
Gabel, Gailene R (Department: 1641)
Chemistry: analytical and immunological testing
For preexisting immune complex or auto-immune disease
C435S006120, C435S007100, C435S007920, C435S287200, C436S507000, C436S508000, C436S516000, C436S517000, C436S008000, C436S015000, C436S175000, C436S177000, C530S350000, C530S353000, C530S358000, C422S067000
Reexamination Certificate
active
07462495
ABSTRACT:
Methods are provided for diagnosing and/or characterizing chronic immune disease activity in a subject. In the subject methods, a sample is obtained from a subject suspected of having or known to have a chronic immune disease. The sample is then assayed for the presence of low molecular actin fragments. The assay results are used to diagnose the presence of chronic immune disease activity and/or characterize chronic immune disease activity in the subject, e.g. to confirm an initial chronic immune disease diagnosis, to determine the stage of the disease, to monitor disease progression, to predict disease attacks, and the like. Also provided by the subject invention are kits for practicing the methods.
REFERENCES:
patent: 4444879 (1984-04-01), Foster et al.
patent: 5766859 (1998-06-01), Vojdani et al.
patent: 5776690 (1998-07-01), Vojdani et al.
patent: 5830668 (1998-11-01), Mordechai et al.
patent: 5853996 (1998-12-01), Mordechai et al.
patent: 5985565 (1999-11-01), Suhadolnik
patent: 6824988 (2004-11-01), Roelens et al.
Strongin, Sensitivity, Specificity, and Predictive Value of Diagnostic Tests: Definitions and Clinical Applications, Laboratory Diagnosis of Viral Infections, Lennette, E., ed., Marcel Dekker Inc., New York, pp. 211-219 (1993).
The Merck Manual, 17thedition, Merck Research Laboratories (1999) pp. 1024-1026, 1041, and 1061-1063.
Willingham et al., Intracellular Localization of Actin in Cultured Fibroblasts by Electron Microscopic Immunochemistry, The Journal of Histochemistry and Cytochemistry 29(1): 17-37 (1981).
R. Suhadolnik et al. “Changes in the 2-5A Synthetase-Rynase L Antiviral Pathway in a Controlled Clinical Trial with poly(I)-Poly(C12U) in Chronic Fatigue Syndrome” (1994)In vivo, 8:599-604.
R. Suhadolnik et al. “Biochemical Evidence for a Novel Low Molecular Weight 2-5A-Dependent Rnase L in Chronic Fatigue Syndrome” (1997)Journal of Interference and Cytokine Research17:377-385.
Komaroff “The Biology of Chronic Fatigue Syndrome,” (2000)Am. J. Med.108:169-171.
Mashima et al. “Caspase-Mediated Cleavage of Cytoskeletal Actin Plays A Positive Role In The Process of Morphological Apoptosis,” (1999)Oncogene, 18:2423-2430.
Meirleir et al. “A 37kDa 2-5A Binding Protein as a Potential Biochemical Marker for Chronic Fatigue Syndrome,” (2000)Am. J. Med., 108:99-106.
Villa et al. “Calpain Inhibitors, but not Calpain Inhibitors, Prevent Actin Proteolysis and DNA Fragmentation During Apotosis,” (1998)J. Cell Sci,111(6):713-722.
D'Haese Anne Marie Yvonne Robert
Englebienne Patrick
Herst Charles Vincent Taylor
Roelens Simon Adriaan Michiel
Bozicevic Field & Francis LLP.
Field Bret E.
Gabel Gailene R
R.E.D. Laboratories N.V.
LandOfFree
Methods and compositions for use in diagnosing and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for use in diagnosing and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for use in diagnosing and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4030003